Vatorsecurities.se använder sig av cookies för att ge dig som besökare en så bra upplevelse som möjligt.

Corporate Finace

Vator Securities provides an extensive range of capital markets and advisory services to cutting-edge public and private growth companies with an emphasis on the Life Sciences, Medical Technology and Diagnostics sectors.

read more

Private Office

Private Office is Vator Securities’ unique investment concept for financial services and is offered only to the company's Core and BlackLine clients. The Private Office concept enables private investors an alternative that has previously been reserved only for institutions.

read more

Klipp från EFNs Börslunch där Vator Securities VD Homan Panahi pratar om det svenska life science-undret och betydelsen för framväxten av nya framgångsrika life science-bolag i Sverige. Se programmet här.

Vator Securities advises Visiopharm on a DKK100 million private placement

ATP, the Danish Growth Fund and the C. L. David Foundation and Collection are among the new investors. The increased capital commitment is an essential part of the company’s growth strategy within the field of tissue diagnostics- and research software for cancer.

read more

Vator Securities Sole Bookrunner in Nanoform SEK 71 million private placement

The private placement was directed to Swedish and Finnish, HNWI, family offices and institutional investors where Mandatum Life Insurance Company (Sampo Group) acted as anchor investor.

read more

Vator Securities advises AlzeCure Pharma on SEK 40 million directed share issue

Vator Securities acted as Sole Bookrunner and Advisor in connection with the transaction raising SEK 40 million.

read more

Sole Bookrunner in the largest ever direct share issue in a diagnostics company in Sweden

Vator Securities Sole Bookrunner in successful SEK 324 million direct share issue in Immunovia, the largest ever in a diagnostics company in Sweden Immunovia´s core technology platform,…

read more

More News